Correction: Smoltek Nanotech Holding AB (publ) interim report Q3 2026

Smoltek corrected its 2026 interim-report release to clarify that third-quarter cash flow from operating activities was SEK -15,404 thousand, compared with SEK -8,244 thousand in the year-earlier quarter. The previously stated figures, SEK -10,952 thousand and SEK -19,472 thousand, referred to January–September rather than the third quarter.

Analysis

This is a reporting-scope correction, not new evidence of a change in Smoltek’s underlying cash generation. The key risk is interpretive: investors using the earlier figures may have mistaken nine-month operating cash flow for quarterly burn, distorting runway estimates and any implied financing timetable. The corrected quarter’s outflow is worse than the stated year-ago quarter, but one quarter alone does not establish a trend; reconcile it to the full interim report, including cash balance, investing cash flow, financing flows, and any subsequent funding disclosures. Near term, expect limited fundamental price discovery unless the correction triggers broader questions about reporting controls or liquidity. Over the next 1–3 months, repeated corrections, a material restatement, or evidence of a shorter cash runway could raise financing and dilution risk. Over 6–18 months, the investment case still depends on commercial progress and the ability to fund development, neither of which this notice establishes. The press release excerpt is incomplete, so verify the full corrected disclosure. No defensible valuation or financing conclusion is available from this item alone.

Key Decisions for Investors

• No trade on the correction alone; avoid treating the previously published nine-month figures as quarterly cash burn.
• Review the corrected interim report for period-by-period operating cash flow, cash and cash equivalents, committed funding, and management’s runway commentary before changing SMOL exposure.
• Set an alert for another correction, delayed reporting, or a financing announcement; these would be more consequential signals of disclosure or dilution risk.
• Falsify the elevated-risk view if the full report reconciles cleanly, liquidity remains adequate for stated plans, and subsequent reporting is consistent.